immunosuppressive therapy

IBD-related colorectal cancer risk raised by chronic inflammation, immunosuppressive therapy

Inflammatory bowel disease-related colorectal cancer risk is raised by chronic inflammation and immunosuppressive therapy. The review was conducted by Dr. Laurent Beaugerie from Hôpital Saint-Antoine in Paris and Dr. Steven H. Itzkowitz from Icahn School of Medicine at Mount Sinai. In the news release, the researchers said, “Among the chronic inflammatory diseases that often require ...click here to read more